Usana Health Sciences Q4 Earnings Assessment

Usana Health Sciences (NYSE:USNA) just disclosed its Q4 earnings on Tuesday, February 17, 2026 at 04:15 PM.

Here's a brief overview of the earnings report.

Earnings

Usana Health Sciences beat estimated earnings by 46.34%, reporting an EPS of $0.6 versus an estimate of $0.41.

Revenue was up $12.59 million from the same period last year.

Earnings History Overview

During the previous quarter, the company missed on EPS by $0.0, leading to a 1.34% drop share price change the next day.

Here's a look at Usana Health Sciences's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.15	0.54	0.70	0.49
EPS Actual	-0.15	0.74	0.73	0.64
Revenue Estimate	213.88M	225.20M	243.04M	208.82M
Revenue Actual	213.67M	235.85M	249.54M	213.61M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Usana Health Sciences management provided guidance for FY 2026, expecting earnings between $1.95 and $2.29 per share.

To track all earnings releases for Usana Health Sciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.